Related Experiment Video
Updated: Apr 7, 2026
Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Comprehensive quantitative analysis of structural and vascular alterations in retinal and choroidal layers in
Sibel Doguizi1, Kemal Tekin1, Fuat Yavrum2
1Ulucanlar Eye Training and Research Hospital, Department of Ophthalmology, Ankara, Turkey.
Purpose:
To quantitatively assess retinal and choroidal thicknesses, as well as microvascular alterations, using spectral-domain optical coherence tomography (SD-OCT) and optical coherence tomography angiography (OCTA) in hydroxychloroquine (HCQ) users.
Methods:
Eighty-one eyes of 81 patients receiving HCQ for rheumatoid arthritis or Sjögren's syndrome were included. Patients were categorized as high-risk (treatment ≥5 years) or low-risk (treatment <5 years) users. SD-OCT, OCTA, and visual fields were obtained. Outer retinal layer and choroidal thicknesses, retinal vascular densities, and choriocapillaris flow areas were assessed, and their correlations with cumulative HCQ dose and treatment duration were analyzed.
Results:
Outer nuclear layer (ONL), outer plexiform layer (OPL), and retinal pigment epithelium (RPE) thicknesses in several macular regions were significantly lower in long-term than in short-term HCQ users (p < 0.05). Choroidal thickness and choriocapillaris flow area were also significantly reduced in long-term users (p < 0.05). Additionally, deep capillary plexus (DCP) vascular density was lower at several locations in the long-term group. HCQ treatment duration and cumulative dose showed significant negative correlations with DCP vascular density, choriocapillaris flow area, choroidal thickness, and ONL thickness (p < 0.05 for each).
Conclusions:
Long-term HCQ use was associated with thinning of the ONL, OPL, RPE, and choroid, accompanied by reduced DCP vascular density and choriocapillaris flow area. These structural and microvascular parameters correlated negatively with treatment duration and cumulative HCQ dose, suggesting subclinical alterations related to cumulative HCQ exposure.
